Infographic: Global access challenges faced by patients with rare diseases
Despite a pick-up in the pace of approvals the last few years, treatments are available for only 5% of the roughly 7,000 rare diseases.
Print Issue: February 01, 2020
Digital health data laws look to enter the 21st century
Health data is governed by laws nearly 25 years old, and as more types of health data are created, from fitness to biometric to genetic data, Washington can’t keep up.
Cost of innovation making fight against superbugs near impossible
Sander Flaum discusses the DISARM act and how we can fight back against antibiotic resistance.
3 rare disease campaigns that conquered challenges around marketing these conditions
We analyze three winning rare disease campaigns that illustrate the challenges and opportunities that come with operating in such a difficult realm.
Can the third PCSK9 drug succeed where the first two failed?
Payers spoiled the debut of the first two PCSK9 drugs from Sanofi and Amgen. A third is poised for approval — but if history is any guide, its U.S. market-access path will be anything but smooth.
2020 Medical Advertising Hall of Fame honoree: The Entrepreneur
Tom Harrison cofounded Harrison & Star.
Medical Advertising Hall of Fame’s 2020 Future Famers
As part of the Medical Advertising Hall of Fame’s annual awards program, agencies nominate their brightest young stars as Future Famers.
2020 Medical Advertising Hall of Fame honoree: The Advisor
Larry Lesser cofounded Medicus Communications and ApotheCom Associates.
2020 Medical Advertising Hall of Fame honoree: The Voice
John Kamp was executive director for the Coalition for Healthcare Communication.
Real-world patient data is revolutionizing clinical trials
The FDA granted Pfizer’s Ibrance a label indication based on real-world data from men using the drug off-label to treat their breast cancer.
